This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Science and Research
Uveitis and Retinal Vascular disease research
Our researchers are devoted to investigating new treatments for this painful and blinding inflammatory eye condition, as well as advancing our scientific understanding of its causes and prognosis.
Overview
We work collaboratively on a number of international clinical trials, investigating new treatments for non-infectious uveitis in children and adults, and determining the best treatment for certain forms or complications of uveitis.
We also have national and international research collaborations that strive to advance our scientific understanding of the cause or prognosis of specific forms of uveitis.
Why this research is important
Uveitis is one of the top five causes of irreversible blindness in Australia. Unlike other causes of blindness, this condition tends to affect children and people of working age, and therefore has a much higher socio-economic impact.
Unfortunately, current uveitis treatments have significant side effects and are not 100% effective. Our research is aimed at finding better treatments, and thereby saving sight.
Key research questions
- Can we find new treatments for non-infectious uveitis that are better tolerated and more effective than those currently available?
- How can we gain a better understanding of the causes and risk factors for the development and progression of uveitis?
- Are there any biomarkers that we can find that will help predict who may get recurrent, or more severe uveitis?